Home»Exposition»NASH (Non-alcoholic Steatohepatitis) Biomarkers Market to Reach $2 Billion by 2025: Increasing Incidence of Chronic Liver Diseases is Expected to Propel Demand in this Market

NASH (Non-alcoholic Steatohepatitis) Biomarkers Market to Reach $2 Billion by 2025: Increasing Incidence of Chronic Liver Diseases is Expected to Propel Demand in this Market

0
Shares
Pinterest Google+
Research and Markets Logo

DUBLIN, August 18, 2017 /PRNewswire/ —
The “NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis By Type, By End-Use (Pharma & CRO Industry, Hospitals, Diagnostic Labs, Academic Research Institutes), And Segment Forecasts, 2014 – 2025” report has been added to Research…

Previous post

Global Cell Line Development Services Markets, 2017-2025 - Stringent and Complex Regulations for Biologics in North America and Europe

Next post

Global Sphygmomanometer Market to Grow at a CAGR of 7.8% by 2021: Analysis By Product & End User